target product profile
accelerated healing of surface wounds
- dry eye (initial product)
- skin wounds
- mucous membranes
- indications
- signs/symptoms dry eye
- epithelial eye damage (wounds), eye burns
qualities
- allogeneic-serum-like, plasma-based
- chitosan
- multiuse, sterile, no preservatives
why plasma
resembles natural tears
growth factors
proteins
embraced by physicians
patient acceptance
extensive clinical data
why chitosan
-
safe medical grade available
-
accelerates wound healing
-
anti-microbial
-
non-immunogenic/ biodegradable
-
versatile excipient
learn more about:
our products
Our therapeutic formulation is suitable for a variety of products, including liquid eye drops, gels, ointments, contact lenses, contoured bandages, and wound dressings. We believe this formulation will promote healing of epithelial (surface cell) disorders, such as dry eye disease, ophthalmic burns, and chronic wounds.
patients
Patients who experience conditions ranging from dry eye disease, to diabetic ulcers, and wounds or burns may benefit from our fusion of plasma and chitosan as a forward-thinking and potent strategy to potentially address their conditions with easier access and fewer side effects.
our platform
Our platform leverages plasma from donated human blood and a proprietary antimicrobial molecule (form of chitosan). The tissue-repairing benefits of plasma-derived products, combined with the sustained action of chitosan, may provide relief and long-lasting therapeutic action.